Telcyta
Navigation Links
Telcyta in Medical News
PALO ALTO, Calif., May 31 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK ) today announced presentation at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Florida, of results from the ASSIST-5 Phase 3 randomized, multinational study of TELCYTA(...
Telik Announces Preclinical Presentations at AACR Annual Meeting
...iscovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...Telik Announces Fourth Quarter and 2008 Year End Financial Results and 2009 Financial Guidance
.... Telik does not undertake any obligation to update forward-looking statements contained in this press release. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. Telik, Inc. St...Telik Announces Year-End Financial Release, Conference Call and Webcast
...overy technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...Telcyta in Medical Technology
Telik Announces Telcyta Clinical and Preclinical Presentations at AACR Meeting
PALO ALTO, Calif., April 09, 2007 /PRNewswire-FirstCall/ -- Telik, Inc. announced that updated clinical data from its multicenter Phase 2 trial of the triplet combination of TELCYTA(R) (canfosfamide HCl, TLK286), carboplatin and paclitaxel will be presented at the 98th annual meeting of the Americ...PALO ALTO, Calif., April 17, 2007 /PRNewswire-FirstCall/ -- Telik, Inc. announced the presentation today of results from a Phase 2 clinical trial of the triplet combination of TELCYTA(R) (canfosfamide HCl, TLK286), carboplatin and paclitaxel in the first-line treatment of advanced non-small cell l...
...very technology, TRAP((R)), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...
Telik Announces Presentation at ASCO Annual Meeting
...iscovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...Telik Announces Initiation of Two Phase 2 Randomized TELINTRA Studies
...ik's results to differ materially from those indicated by these forward-looking statements, including, among others, if clinical trials of TELINTRA or telcyta are delayed or unsuccessful, Telik's business would suffer, if Telik's competitors develop and market products that are more effective than its produc...Telcyta in Biological Technology
FDA Removes Partial Hold on TELCYTA Clinical Development
PALO ALTO, Calif., Oct. 15 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK ) announced that the U.S. Food and Drug Administration (FDA) has removed the partial hold on TELCYTA(R) (canfosfamide HCl, TLK286) clinical trials. This action follows a complete review of TELCYTA data by the agenc...Telik Announces Second Quarter 2009 Financial Results
...king statements, including, among others, if clinical trials of TELINTRA or telcyta are delayed or unsuccessful, Telik's business would suffer, if Telik's comp...ts contained in this press release. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...Telik Reports Preclinical Results at AACR Annual Meeting
...iscovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...Telik Implements Reorganization to Focus Resources Toward Drug Development Pipeline
...iodic filings with the SEC. The Company does not undertake any obligation to update forward-looking statements. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...Telik Announces Financial Results for 2008 Third Quarter
...2008. Telik does not undertake any obligation to update forward-looking statements contained in this press release. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. Telik, Inc. Statements of Op......ts from an interrupted Phase 3 randomized study of telcyta (canfosfamide HCL) in combination with pegylated l...gression-free survival (PFS) was 5.6 months on the telcyta plus PLD arm compared to 3.7 months on the PLD con...um resistant disease, including 40 patients on the telcyta plus PLD arm and 35 patients on the PLD control ar...
Telik Announces 2008 Third Quarter Financial Release, Conference Call and Webcast
...g discovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...Telik Announces Financial Results For 2008 Second Quarter
...2008. Telik does not undertake any obligation to update forward-looking statements contained in this press release. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. Telik, Inc. Statements of O...Telik Announces 2008 Second Quarter Financial Release, Conference Call and Webcast
...g discovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...Telik Announces First Quarter 2008 Financial Results
...oking" statements, including statements regarding the future development of telcyta and TELINTRA. These forward-looking statements are based upon Telik's curre... forward-looking statements, including, among others, if clinical trials of telcyta or TELINTRA are delayed or unsuccessful, Telik's business would suffer, if ...Other TagscanceroustiedoxideoxideoxideshipshipshipOther Contentsforebrainforebrainforebrainfossilfossilfossilfossilfossilfrondframeshiftfungifungifungifungifungifungifructosefructosefructosefructosefructosefusionfusionfusionfusionfusionfusionfusionfusionfusion
(Date:11/25/2009)...rological symptoms, study finds , , WED...ide effects are among the potential problems faced...ere treated with cisplatin-based chemotherapy, a n...Norwegian men treated for unilateral testicular ca...ow-up survey conducted from 1998 to 2002. , The...
(Date:11/25/2009)...ire/-- MISSIONSkincare ®isproudtosupportGNC,s...GNC,sannualSt.Jude ThanksandGiving campaign,$1from...PER-C(TM)LipBalm willbedonatedtoSt.Jude.Additional...donationatcheckoutatoneoftheir5,000+retaillocation....Judeduringtheir2009 ThanksandGiving campaign. ,...
(Date:11/25/2009)...wnforthe4thStraightYear ,, WASHINGTON,Nov.25/...-Georgia(LCA-GA)issuedthe 4thAnnualReportCardonLun...deagainstthislethaldiseaseinthestateofGeorgia.LCA-...nalorganizationdedicatedexclusivelytopatientsuppor...er. ,, (Logo: http://www.newscom.com/cgi-bin/pr...
(Date:11/25/2009)...tal cancer also can reverse a rare stomach disorde...the disease, researchers at Vanderbilt University ...ase causes thickening of the stomach lining, sever...anemia and swelling in the feet and ankles due to ...astric cancer. Previously, the only effective trea...
(Date:11/25/2009)...e skin kill tumor cells, study finds , ,...accine delivered in a fingernail-size implant elim...s. , The method uses polymer disks, 8.5 millime...fic antigens and implanted under the skin to repro...rd University scientists who developed the implant...
Breaking Medicine News(10 mins):Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2[0] Long-Term Problems Linked to Testicular Cancer Chemo[2] MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R)[0] Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer[1] Vanderbilt scientists report first effective medical therapy for rare stomach disorder[2] Implantable Cancer Vaccine Shows Promise
(Date:11/23/2009)...ommunity-associated strain of the deadly superbug ...t common antibioticsposes a far greater health thr...to hospitals, according to a study in the December... new threat is easily picked up in fitness centers...ed the overall burden of MRSA within hospitals, th...
(Date:11/23/2009)...ldlife Conservation Society says that western lowl...ic of Congopart of the "mother lode" of more than ...increasingly threatened by growing humans activity...n of the swamp forests adjacent to the southwest b...veys confirmed that high densities of the great ap...
(Date:11/23/2009)...w study provides "incontrovertible evidence" that ...of Sumatra about 73,000 years ago deforested much ...ter, researchers report. , The volcano ejected a...tmosphere, leaving a crater (now the world,s large...35 kilometers wide. Ash from the event has been fo...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Free LASIK Surgery Webinar 62029 1Free LASIK Surgery Webinar 62029 2Free LASIK Surgery Webinar 62029 3Free LASIK Surgery Webinar 62029 4TeamStaff Announces Transfer to Nasdaq Capital Market 62025 1TeamStaff Announces Transfer to Nasdaq Capital Market 62025 2TeamStaff Announces Transfer to Nasdaq Capital Market 62025 3Lives Compromised and Patient Access Limited with New Cuts to Medicare 62021 1Lives Compromised and Patient Access Limited with New Cuts to Medicare 62021 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |